NCT03985527 - Janus Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

March 31, 2025

Study Completion Date

June 30, 2025

Conditions

Sleep Apnea Syndromes

Interventions

DEVICE

Transvenous nerve stimulation

Acute transvenous nerve stimulation during a commercial implant of remedē® System or commercial transvenous cardiac device (de novo pacemaker or implantable cardiac defibrillator).

Trial Locations (3)

19010

RECRUITING

Bryn Mawr Medical Specialists Association, Bryn Mawr

27013

RECRUITING

Novant Health Forsyth Medical Center, Winston-Salem

43210

RECRUITING

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors

lead

Respicardia, Inc.

INDUSTRY